Beta Drugs Ltd Financial Statement
*All values are in Rs. Cr
No Data Available
Invest in Beta Drugs Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 197.62 | 157.87 | 124.85 |
| Operating Expenses Annual | 164.10 | 126.68 | 99.66 |
| Operating Profit Annual | 35.26 | 32.24 | 26.04 |
| Interest Annual | 1.05 | 0.84 | 0.41 |
| Depreciation | 4.72 | 6.19 | 5.47 |
| Net Profit Annual | 21.94 | 18.82 | 14.25 |
| Tax Annual | 7.55 | 6.39 | 5.92 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 197.62 |
| Operating Expenses Annual | 164.10 |
| Operating Profit Annual | 35.26 |
| Interest Annual | 1.05 |
| Depreciation | 4.72 |
| Net Profit Annual | 21.94 |
| Tax Annual | 7.55 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 17.79 | 15.58 | 8.27 |
| Cash Flow from Operations | 21.19 | 10.23 | 18.76 |
| Cash Flow from Investing | -11.02 | -5.82 | -12.72 |
| Cash Flow from Financing | -0.76 | -2.19 | 1.27 |
| Cash Flow at the End | 27.20 | 17.79 | 15.58 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 17.79 |
| Cash Flow from Operations | 21.19 |
| Cash Flow from Investing | -11.02 |
| Cash Flow from Financing | -0.76 |
| Cash Flow at the End | 27.20 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 17.84 | 20.42 | 20.86 |
| PBIT Margin (%) | 15.45 | 16.50 | 16.48 |
| PBT Margin (%) | 0.73 | -3.14 | -23.73 |
| Net PROFIT Margin (%) | 11.10 | 11.92 | 11.41 |
| Return On Networth / Equity (%) | 20.67 | 21.67 | 20.23 |
| Return On Networth /Employed (%) | 26.60 | 27.20 | 26.19 |
| Return On Assets (%) | 19.10 | 19.67 | 18.15 |
| Total Debt / Equity (X) | 0.05 | 0.07 | 0.09 |
| Asset Turnover Ratio (%) | 1.72 | 1.65 | 1.59 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 17.84 |
| PBIT Margin (%) | 15.45 |
| PBT Margin (%) | 0.73 |
| Net PROFIT Margin (%) | 11.10 |
| Return On Networth / Equity (%) | 20.67 |
| Return On Networth /Employed (%) | 26.60 |
| Return On Assets (%) | 19.10 |
| Total Debt / Equity (X) | 0.05 |
| Asset Turnover Ratio (%) | 1.72 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 36.48 | 34.77 | 34.06 |
| Total Current Assets Annual | 113.67 | 85.00 | 62.76 |
| Non Current Assets Annual | 56.80 | 49.04 | 48.14 |
| Total Shareholders Funds Annual | 116.01 | 96.26 | 77.46 |
| Total Assets Annual | 170.47 | 134.04 | 110.90 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 36.48 |
| Total Current Assets Annual | 113.67 |
| Non Current Assets Annual | 56.80 |
| Total Shareholders Funds Annual | 116.01 |
| Total Assets Annual | 170.47 |
No Data Availabe
